TLSA (Tiziana Life Sciences Ltd. Common Shares) Stock Analysis - Financials

Tiziana Life Sciences Ltd. Common Shares (TLSA) is a publicly traded Healthcare sector company. As of May 19, 2026, TLSA trades at $1.38 with a market cap of $171.80M and a P/E ratio of 0.00. TLSA moved +2.96% today. Year to date, TLSA is -13.75%; over the trailing twelve months it is -6.76%. Its 52-week range spans $0.63 to $2.60. Rallies surfaces TLSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are TLSA's key financials?

TLSA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TLSA recently traded at $1.38. Market cap is $171.80M. P/E ratio is 0.00. Revenue is $0.

TLSA Key Metrics

Key financial metrics for TLSA
MetricValue
Price$1.38
Market Cap$171.80M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$2.60
52-Week Low$0.63
Volume243.75K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest TLSA News

TLSA Analyst Consensus

TLSA analyst coverage data. Average price target: $0.00.

Common questions about TLSA

What are TLSA's key financials?
TLSA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TLSA recently traded at $1.38. Market cap is $171.80M. P/E ratio is 0.00. Revenue is $0.
Is TLSA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TLSA. It does not provide personalized investment advice.
TLSA

TLSA